RxSight, Inc. (RXST)
4.81
-0.04
(-0.82%)
USD |
NASDAQ |
Oct 09, 16:00
4.815
0.00 (0.00%)
After-Hours: 20:00
RxSight Free Cash Flow : -27.16M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -27.16M |
| March 31, 2026 | -21.58M |
| December 31, 2025 | -19.34M |
| September 30, 2025 | -22.20M |
| June 30, 2025 | -20.80M |
| March 31, 2025 | -20.52M |
| December 31, 2024 | -22.39M |
| September 30, 2024 | -28.76M |
| June 30, 2024 | -37.07M |
| March 31, 2024 | -41.18M |
| Date | Value |
|---|---|
| December 31, 2023 | -48.64M |
| September 30, 2023 | -51.38M |
| June 30, 2023 | -58.47M |
| March 31, 2023 | -64.77M |
| December 31, 2022 | -61.39M |
| September 30, 2022 | -56.26M |
| June 30, 2022 | -54.50M |
| March 31, 2022 | -51.25M |
| December 31, 2021 | -46.65M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Precision Optics Corp., Inc. | -1.982M |
| UFP Technologies, Inc. | 61.42M |
| TransMedics Group, Inc. | 79.04M |
| Hyperfine, Inc. | -27.53M |
| Abbott Laboratories | 7.824B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.538M |
| Cash from Investing (Quarterly) | 4.652M |
| Cash from Financing (Quarterly) | 0.662M |
| Free Cash Flow Per Share (Quarterly) | -0.277 |
| Free Cash Flow to Equity (Quarterly) | -11.25M |
| Free Cash Flow to Firm (Quarterly) | -11.49M |
| Free Cash Flow Yield | -13.70% |